Trader consensus reflects an 88.5% implied probability of no new pandemic in 2026, anchored in World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) surveillance data showing no novel pathogen achieving sustained human-to-human transmission at global scale. The Democratic Republic of Congo's April 2 declaration ending its two-year mpox outbreak—over 2,200 deaths but regionally contained—marks a key de-escalation, while H5N1 avian influenza reports confirm isolated human cases without chains of transmission. U.S. measles outbreaks surpass 1,500 cases linked to vaccination gaps in known virus, not a new threat. COVID-19 risks remain moderate per WHO's February assessment. Ongoing monitoring of emerging signals and forecast updates from agencies underpin this skin-in-the-game positioning, though viral mutations pose tail risks.